Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
01.11.2016 21:14:53

Gilead Sciences Inc. Reveals 24% Fall In Q3 Earnings

(RTTNews) - Gilead Sciences Inc. (GILD) reported earnings for third quarter that retreated from last year.

The company said its earnings totaled $3.68 billion, or $2.75 per share. This was down from $4.84 billion, or $3.22 per share, in last year's third quarter.

Analysts had expected the company to earn $2.86 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter fell 9.6% to $7.50 billion. This was down from $8.30 billion last year.

Gilead Sciences Inc. earnings at a glance:

-Earnings (Q3): $3.68 Bln. vs. $4.84 Bln. last year. -Earnings Decline (Y-o-Y): -24.0% -EPS (Q3): $2.75 vs. $3.22 last year. -EPS Decline (Y-o-Y): -14.6% -Analysts Estimate: $2.86 -Revenue (Q3): $7.50 Bln vs. $8.30 Bln last year. -Revenue Change (Y-o-Y): -9.6%

-Guidance: Full year EPS guidance: $1.47 - $1.53

Analysen zu Gilead Sciences Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Gilead Sciences Inc. 86,84 -0,36% Gilead Sciences Inc.